Found: 29
Select item for more details and to access through your institution.
The Oncology Association of Naturopathic Physicians Principles of Care Guidelines.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 8, doi. 10.3747/co.26.4955
- By:
- Publication type:
- Article
Clinical trial implications for study participants accessing medical assistance in dying.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 10, doi. 10.3747/co.26.4609
- By:
- Publication type:
- Article
Oncology Association of Naturopathic Physicians: Principles of Care Guidelines.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 12, doi. 10.3747/co.26.4815
- By:
- Publication type:
- Article
Adopting patient-centred tools in cancer care: role of evidence and other factors.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 19, doi. 10.3747/co.26.4271
- By:
- Publication type:
- Article
Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 28, doi. 10.3747/co.26.4389
- By:
- Publication type:
- Article
Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 37, doi. 10.3747/co.26.4096
- By:
- Publication type:
- Article
Palliative care for cancer patients near end of life in acute-care hospitals across Canada: a look at the inpatient palliative care code.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 43, doi. 10.3747/co.26.4563
- By:
- Publication type:
- Article
Integrating primary care providers through the seasons of survivorship.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 48, doi. 10.3747/co.26.4687
- By:
- Publication type:
- Article
Building capacity in cancer knowledge translation through catalyst grants.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 55, doi. 10.3747/co.26.4801
- By:
- Publication type:
- Article
Factors influencing the use by radiation therapists of cancer symptom guides: a mixed-methods study.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. 56, doi. 10.3747/co.26.4198
- By:
- Publication type:
- Article
Secondary polycythemia in a sarcoma patient: a commentary about cediranib.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e1, doi. 10.3747/co.26.4385
- By:
- Publication type:
- Article
Prevalence of human T cell lymphotropic virus 1 infection in Canada.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e3, doi. 10.3747/co.26.4593
- By:
- Publication type:
- Article
Ferocious beast.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e6, doi. 10.3747/co.26.4341
- By:
- Publication type:
- Article
Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e8, doi. 10.3747/co.26.4160
- By:
- Publication type:
- Article
Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e17, doi. 10.3747/co.26.4068
- By:
- Publication type:
- Article
Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e24, doi. 10.3747/co.26.4217
- By:
- Publication type:
- Article
Prognostic value of inflammation-based markers in advanced or metastatic neuroendocrine tumours.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e30, doi. 10.3747/co.26.4135
- By:
- Publication type:
- Article
Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e39, doi. 10.3747/co.26.4203
- By:
- Publication type:
- Article
Effects of magnanimous therapy on coping, adjustment, and living function in advanced lung cancer.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e48, doi. 10.3747/co.26.4126
- By:
- Publication type:
- Article
Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e57, doi. 10.3747/co.26.4167
- By:
- Publication type:
- Article
Factors influencing the outcome of stereotactic radiosurgery in patients with five or more brain metastases.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e64, doi. 10.3747/co.26.4244
- By:
- Publication type:
- Article
A multidisciplinary perspective on the subcutaneous administration of trastuzumab in HER2-positive breast cancer.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e70, doi. 10.3747/co.26.4220
- By:
- Publication type:
- Article
Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e81, doi. 10.3747/co.26.4116
- By:
- Publication type:
- Article
Patient indications for Mohs micrographic surgery: a clinical practice guideline.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e94, doi. 10.3747/co.26.4439
- By:
- Publication type:
- Article
Conditional approval of cancer drugs in Canada: accountability and impact on public funding.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e100, doi. 10.3747/co.26.4397
- By:
- Publication type:
- Article
Extended venous thromboembolism prophylaxis after abdominopelvic cancer surgery: a retrospective review.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e106, doi. 10.3747/co.26.4339
- By:
- Publication type:
- Article
Diabetes mellitus secondary to treatment with immune checkpoint inhibitors.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e111, doi. 10.3747/co.26.4151
- By:
- Publication type:
- Article
A case of nivolumab-induced acute-onset type 1 diabetes mellitus in melanoma.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e115, doi. 10.3747/co.26.4130
- By:
- Publication type:
- Article
Brigatinib is another treatment option for patients diagnosed with advanced ALK-positive non-small-cell lung cancer who are treatment-naïve or who have progressed on or are intolerant to crizotinib.
- Published in:
- Current Oncology, 2019, v. 26, n. 1, p. e119, doi. 10.3747/co.26.4809
- By:
- Publication type:
- Article